<DOC>
	<DOCNO>NCT02048397</DOCNO>
	<brief_summary>The effect Pulmonary Rehabilitation patient bronchiectasis ( BC ) sufficiently study . The aim study assess clinical biological response Pulmonary Rehabilitation Program ( PRP ) 12 week BC v PRP plus hyperproteic oral nutritional supplement enrich beta-hydroxy-beta-methylbutyrate ( HMB ) . Methods : single center randomize controlled trial , parallel treatment design : Participants randomize assign either receive ( n=14 ) PRP 60 minute , two supervise session per week hospital one unsupervised session home v PRP ( n=14 ) plus ONS ( one per day ) . Outcome assessment perform baseline , 12 week 24 week : 1.- effort capacity &amp; # 8211 ; cardiopulmonary exercise test- , 2.- body composition ( anthropometry , lean body mass dual energy X-ray absorptiometry bioimpedance , phase angle ) , 3.- peripheral muscle strength ( dynamometry respiratory -PEM ( maximum expiratory pressure ) PIM ( minimum expiratory pressure ) - ) , 4.- spirometry , 5.- respiratory symptom ( bronchorrhea , dyspnoea , exacerbation ) ,6.- level physical activity ( IPAQ questionnaire plus objective physical activity ( WGT3X ) ) , 7.- quality life ( QOL-B-Spain ) , 8.-psychological symptom ( HASD ) 9.- biological marker inflammation ( leptin , adiponectin , interleukin-6 , tumor necrosis factor-alpha , ultrasensitive C-reactive protein , GPR55 ( G protein-coupled receptor 55 ) RNAm ( messenger ribonucleic acid ) expression white blood cell ) oxidation ( total antioxidant capacity , superoxide dismutase activity , 8-iso-prostaglandin F2a , Thiobarbituric acid reactive substance ) .</brief_summary>
	<brief_title>Pulmonary Rehabilitation Program ( PRP ) Versus PRP Plus Nutritional Supplementation Patients With Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Patients age 1880 ( include ) Patients bronchiectasis , cystic fibrosis bronchiectasis . Bronchiectasis diagnose high resolution compute tomography ( HRCT ) . chest Patients follow Bronchiectasis Cystic Fibrosis Units Hospital . BMI &gt; 18.5 patient 65 year old , &gt; 20kg/m2 patient age . Ambulatory patient . Use oral corticoid . Respiratory exacerbation . If patient respiratory exacerbation recent hospital admission , participation postpone least 60 day til acute disease resolve . Prior oral parenteral supplement intake . Traumatological , neurological cardiovascular disease prevent patient perform training . Life threaten hemoptysis past year . Patients cancer , major surgery previous three month , participate another study , patient pregnant may become pregnant , patient acute intestinal disease , acute heart failure , severe hepatic failure dialysis . Gastrectomy , gastroparesis alteration gastric empty . Enteral tube feeding , galactosemia , Fructosemia . Allergy known sensitivity ingredient enteral formula . Cystic fibrosis . Included active list transplantation . Drug alcohol abuse . No informed consent sign .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Bronchiectasis .</keyword>
</DOC>